Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0013421 (
dystonia
)
8,418
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Potential adverse effects of estrogen-gestagen contraceptive agents on blood pressure were studied in 220 fertile women (19 to 45 years old) throughout 2152 menstrual cycles. The contraceptive agents used were ovidon, non-ovlon, rigevidon and triquilar. Blood pressure was measured prior to administration of contraceptive agents, after 3, 6, 9 and 12 months of administration, and 1 month after termination of administration of estrogen-gestagen contraceptives. Evaluation of the cardio-vascular status indicated that of 220 women 212 had various risk factors for elevated blood pressure: 28 had excessive body weight, 14 were older than 35 years, 21 had a history of
complicated pregnancy
and labor, 2 had neurocirculatory
dystonia
, 54 had family history of cardio- vascular diseases, 70 smoked at least 20 cigarettes; more than on half of women (163) complained of headache of various severity. Each risk factor was assigned a rank of 1 (weak), 2 (moderate), or 3 (strong). All contraceptive agents tested had an effect on blood pressure. The most pronounced elevation of blood pressure was observed after administration of ovidon: statistically significant increase of the systolic blood pressure was observed after 3-month administration and after 1 year this parameter exceeded the initial values by 6-7 mm Hg. During the use of non-ovlon, significant increase of the systolic blood pressure was first observed later, after 6 months, and 1 year later it exceeded the initial values only by 3-4 mm Hg. Significant increase of the diastolic pressure (by 3-6 mm Hg) was observed only after 9 months of ovidon administration and after 1 year of non-ovlon administration. Contraceptive agents with reduced dosage of steroid components (rigevidon or triquilar) produced less pronounced increase in systolic or diastolic blood pressure (less than by 2-3 mm Hg). The changes in blood pressure after the use of ovidon and non-ovlon were more pronounced in women with combined rank of risk factors of 7.
...
PMID:[Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history]. 247 38
On the cross histotopographic sections of 76 cords individual differences in the location of two arteries and veins of cord have been studied. The data are obtained on the changes of morphometric parameters of cord in normal and
complicated pregnancy
(obesity, neurocirculatory
dystonia
in hypertension type and miscarriages).
...
PMID:[Differences in the arrangement and morphometric characteristics of the umbilical blood vessels]. 1058 79